| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |